Company Profile

Shandong VNYA Biotechnology Co., Ltd. (hereinafter referred to as VNYA), is fully committed to VNYA Solid Phase extraction automated system, qualitative and quantitative detection of mycotoxins (including reagents and instruments), mycotoxins affinity columns, R & D, production and sales of monoclonal antibodies and bioengineered recombinant antigens, providing customers with professional automated solid phase extraction (SPE) instrument combined with mycotoxin affinity columns, and one-stop solution products and related services for mycotoxin quantitative detection.

VNYA headquartered in Vancouver, Canada, with a 3000-square-meter R & D center and industrialization base. VNYA has established a complete colloidal gold and latex labeling chromatography technology platform, a latex labeling quantistative detection technology platform, an antibody affinity chromatography column technology platform, a monoclonal antibody R & D technology platform, and a Solid Phase extraction automated system and production platforms.

The current products focus on mycotoxins, including 8 major mycotoxins:aflatoxin, zearalenone, and vomiting toxin and so on. The products have been widely used in many fields such as grain, feed, medicinal materials, and alcohol content determination. The service covers food and drug supervision, inspection and quarantine, animal husbandry and forestry, and other institutions and institutions, and provides professional product support for many companies such as dairy products, food processing, feed processing, and agricultural product processing.

VNYA's sales team can help customers deal with a variety of issues with a one-stop service: including on-site training, commissioning and free trial of VNYA SPE system, and provide customers with a variety of diagnostic test products and a wide range of auxiliary products and services, adhere to the principle of customer first.